by Biological seed treatment involves the application of various biological agents such as microbial formulations, botanical derivatives, and other organic compounds on seeds to enhance plant growth and yields. Some common biological seed treatment products include microbials, plant extracts, and other organic compounds. Trichoderma species are extensively used as microbial inoculants for seed treatment as they help in the growth of plant roots and prevent damage from soil-borne pathogens. Manufacturers are also developing biological seed treatment products from plant extracts containing compounds such as fatty acids, terpenes, phenolics, and biosurfactants. The global biological seed treatment market is mainly driven by the rising demand for organic and sustainable agricultural practices. Growing concerns regarding the adverse effects of synthetic pesticides and herbicides on the environment and human health have amplified the adoption of biological alternatives.
The global Biological Seed Treatment Market is estimated to be valued at US$1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
One of the key drivers for the growth of the biological seed treatment market is the growing demand for organic farming. Consumers are increasingly preferring organic products due to rising health awareness. This has prompted farmers to adopt organic practices and use biological inputs like biofertilizers and biological seed treatments. Biological seed treatments help organic farmers to obtain improved yields and manage soil fertility without using synthetic chemical additives. The increasing uptake of organic farming worldwide is thus expected to propel the demand for biological seed treatments during the forecast period. Another driver for this market is the need for sustainable agricultural practices. Excessive use of agricultural chemicals has adverse effects on the soil ecosystem and environmental quality over the long run. Biological seed treatments are emerging as a viable eco-friendly alternative due to advantages like improved soil health. Leading manufacturers are engaged in research & development of biological seed treatment formulations using active ingredients like plant extracts, microbial inoculants that not only protect seeds and crops but also naturally enhance soil productivity. Such innovative sustainable products are gaining traction among growers globally, thereby contributing to market growth.
Segment Analysis
The Biological Seed Treatment Market Demand can be segmented into biopesticides, biofertilizers, and biostimulants. Within biopesticides, microbials dominate as they help control various soil-borne diseases and protect seeds and seedlings. Microbial pesticides are more environmentally friendly than chemical pesticides and do not contaminate the soil or pollute groundwater.
PEST Analysis
Political: Governments globally are promoting sustainable agricultural practices and imposing regulations to reduce chemical pesticide and fertilizer usage. This is driving demand for biological alternatives.
Economic: Farmers are willing to pay higher costs for biological seed treatments as they help reduce chemical inputs and improve yield over the long-run. The production of biologicals also creates rural employment.
Social: Consumers are increasingly preferring food grown with organic or sustainable practices. This has increased awareness among farmers about utilizing biological products.
Technological: Ongoing R&D is improving formulations to make biologicals more effective and compatible with mechanized seeding. Digital technologies also enable the precision application of biological treatments.
Key Takeaways
The global biological seed treatment market is expected to witness high growth over the forecast period, driven by the need for environment-friendly practices and government promotion of solutions. The global biological seed treatment Market is estimated to be valued at US$1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Regional analysis
The Asia Pacific region is the fastest growing market for biological seed treatment. Countries such as India have been promoting inorganic farming through programs that subsidize bioinput costs. With nearly 60% of the population dependent on agriculture, the Indian government’s push for sustainable practices is driving heavy adoption of biological seed treatments.
Key players
Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
